XML 84 R75.htm IDEA: XBRL DOCUMENT v3.25.2
Investments in and Advances to Joint Ventures - Summary of Financial Information for Consolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Schedule Of Equity Method Investments [Line Items]          
Current assets $ 2,593,895   $ 2,593,895   $ 2,462,400
Total assets 5,721,165   5,721,165   5,487,962
Current liabilities 1,607,760   1,607,760   1,915,644
Total liabilities 3,099,554   3,099,554   2,953,473
Total joint venture equity 2,515,871   2,515,871   2,416,389
Revenue 1,584,323 $ 1,670,467 3,138,683 $ 3,206,143  
Costs 1,235,970 1,318,931 2,436,347 2,529,758  
Net income attributable to Parsons Corporation 55,230 69,172 121,433 108,922  
Net income attributable to noncontrolling interests 15,259 11,547 30,843 26,790  
Consolidated Joint Ventures          
Schedule Of Equity Method Investments [Line Items]          
Current assets 511,620   511,620   519,450
Noncurrent assets 7,245   7,245   9,841
Total assets 518,865   518,865   529,291
Current liabilities 306,812   306,812   296,774
Noncurrent liabilities 3,063   3,063   2,203
Total liabilities 309,875   309,875   298,977
Total joint venture equity 208,990   208,990   $ 230,314
Revenue 192,795 186,731 389,153 388,748  
Costs 162,068 163,287 327,022 334,435  
Net income attributable to Parsons Corporation 30,727 23,444 62,131 54,313  
Net income attributable to noncontrolling interests $ 15,259 $ 11,547 $ 30,843 $ 26,790